MEDI-7979 - USA (New York) - Cytopathology and Next Generation Sequencing Testing Services - Deadline August 21,2026

Vendor needs to provide cytopathology and next generation sequencing testing services to the government authority located in NY.– Provide comprehensive, clinically validated molecular diagnostic testing using to improve the evaluation and management of thyroid nodules with indeterminate cytology, enhancing diagnostic accuracy, reducing unnecessary surgeries, and guiding timely intervention for patients at risk.